文献速递神经肌肉病

两个丹麦2型糖尿病队列中的血脂水平与糖尿病多发性神经病变风险

Lipid Levels and Risk of Diabetic Polyneuropathy in 2 Danish Type 2 Diabetes Cohorts.
PubMed 文献 · Neurology · 2024-06-04

基于丹麦两个2型糖尿病队列(人群队列61,853人,临床队列4,823人),评估血脂参数与糖尿病多发性神经病变(DPN)风险的关联。达到HDL、LDL及非HDL胆固醇指南目标与DPN风险无关,而甘油三酯>204 mg/dL(2.3 mmol/L)与DPN风险升高相关(人群队列调整HR 1.28,临床队列调整PR 1.40)。

要点

  • 甘油三酯>204 mg/dL(2.3 mmol/L)与DPN风险升高相关,人群队列调整HR 1.28(95%CI 1.13-1.45)。
  • 临床队列中DPN患病率18%,甘油三酯>204 mg/dL者调整PR 1.40(95%CI 1.21-1.62)。
  • 达到HDL、LDL及非HDL胆固醇指南目标与DPN风险无关联。

核心结论

  • 高甘油三酯水平是DPN的强危险因素。
  • 未来干预性研究需确定降低甘油三酯是否比降低其他血脂对预防DPN更重要。

研究设计与样本

  • 基于人群的新诊断2型糖尿病队列研究,纳入61,853人,中位年龄63岁(四分位54-72岁)。
  • 临床招募的2型糖尿病横断面研究,纳入4,823人,中位年龄65岁(四分位57-72岁)。

主要发现

  • 人群队列中医院诊断DPN的发病率为3.6/1000人年,中位随访7.3年。
  • 人群队列中甘油三酯150-204 mg/dL(1.7-2.3 mmol/L)者调整HR为1.02(95%CI 0.89-1.18),>204 mg/dL(2.3 mmol/L)者调整HR为1.28(95%CI 1.13-1.45)。
  • 临床队列DPN患病率18%,甘油三酯>204 mg/dL(2.3 mmol/L)者调整PR为1.40(95%CI 1.21-1.62)。
  • 男性HDL胆固醇<39 mg/dL(1.0/1.3 mmol/L)及女性<50 mg/dL(1.3 mmol/L)者DPN患病率轻度升高,PR 1.13(95%CI 0.99-1.28)。
  • 非HDL胆固醇>131 mg/dL(3.4 mmol/L)者DPN患病率轻度升高,PR 1.27(95%CI 1.05-1.52)。

关键数值与推荐

  • 血脂参数按最新血脂异常临床指南切点分类。
  • DPN在人群队列中用经验证的医院诊断编码评估,在临床队列中用密歇根神经病变筛查量表问卷评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Reduction of blood lipids may aid in preventing diabetic polyneuropathy (DPN), but evidence remains conflicting. We investigated the association between lipid parameters and DPN risk in individuals with type 2 diabetes mellitus (T2DM). METHODS: We conducted a population-based cohort study of individuals with newly diagnosed T2DM and a cross-sectional study using a clinically recruited T2DM cohort. Triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and non-HDL cholesterol were measured in routine diabetes care. Each lipid parameter was categorized according to the latest cutoffs in clinical guidelines on dyslipidemia. DPN was assessed with validated hospital diagnosis codes in the population-based cohort and with the Michigan Neuropathy Screening Instrument questionnaire in the clinical cohort. We calculated hazard ratios (HRs) using Cox regression and prevalence ratios (PRs) using Poisson regression. RESULTS: We included 61,853 individuals in the population-based cohort (median age 63 [quartiles 54-72] years) and 4,823 in the clinical cohort (median age 65 [quartiles 57-72] years). The incidence rate of hospital-diagnosed DPN in the population-based cohort was 3.6 per 1000 person-years during a median follow-up of 7.3 years. Achieving guideline targets for HDL, LDL, and non-HDL cholesterol showed no association with DPN risk. By contrast, adjusted HRs (95% CI) for DPN were 1.02 (0.89-1.18) for triglyceride levels between 150 and 204 mg/dL (1.7-2.3 mmol/L) and 1.28 (1.13-1.45) for levels >204 mg/dL (2.3 mmol/L). In the clinical cohort with a DPN prevalence of 18%, DPN associated strongly with triglycerides >204 mg/dL (2.3 mmol/L) with an adjusted PR (95% CI) of 1.40 (1.21-1.62). The prevalence of DPN was modestly elevated for individuals with HDL cholesterol <39 mg/dL (1.0/1.3 mmol/L) in men and <50 mg/dL (1.3 mmol/L) in women (PR 1.13 [0.99-1.28]) and for individuals with non-HDL cholesterol >131 mg/dL (3.4 mmol/L) (PR 1.27 [1.05-1.52]). In both cohorts, spline models showed an increasing risk of DPN starting from triglyceride levels >124 mg/dL (1.4 mmol/L). All results were similar among statin users. DISCUSSION: High triglyceride levels are a strong DPN risk factor. Future intervention studies shall determine whether triglyceride reduction is more important for DPN prevention than reduction of other lipids.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kristensen FPB, Christensen DH, Callaghan BC, et al. Lipid Levels and Risk of Diabetic Polyneuropathy in 2 Danish Type 2 Diabetes Cohorts. Neurology. 2024. PMID: 38833657. doi:10.1212/WNL.0000000000209538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。